NCT05965778View on ClinicalTrials.gov

Comparison of the Performance and Safety of T2769 Versus Vismed® Multi in the Treatment of Moderate to Severe Dry Eye Syndrome

NAUnknownINTERVENTIONAL

Enrollment

226

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions

Dry Eye

Interventions

DEVICE

T2769

T2769: sodium hyaluronate, Trehalose, Naaga in a 12.5 mL ABAK® multi-dose bottle.

DEVICE

Vismed® Multi

Hyaluronic acid

Trial Locations (1)

63003

RECRUITING

Gabriel-Montpied University Hospital, Clermont-Ferrand

Sponsors

Lead Sponsor

Laboratoires Thea

All Listed Sponsors

lead

Laboratoires Thea

INDUSTRY